The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile

BACKGROUND: Weight loss therapy is becoming more and more important, and two classes of molecules, namely amylin receptor and GLP-1 receptor agonists, have shown promise in this regard. Interestingly, these molecules have several overlapping pharmacological effects, such as suppression of gastric em...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Anna Thorsø, Gydesen, Sofie, Sonne, Nina, Karsdal, Morten Asser, Henriksen, Kim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791885/
https://www.ncbi.nlm.nih.gov/pubmed/33413317
http://dx.doi.org/10.1186/s12902-020-00678-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791885/
https://www.ncbi.nlm.nih.gov/pubmed/33413317
http://dx.doi.org/10.1186/s12902-020-00678-2

Ejemplares similares